Epidemic history of hepatitis c virus infection in two remote communities in Nigeria, West Africa

Journal of General Virology

Volumn 93, Issue PART 7, 2012, Pages 1410-1421

  Forbi, Joseph C ^a   Purdy, Michael A ^a   Campo, David S ^a   Vaughan, Gilberto ^a   Dimitrova, Zoya E ^a   Ganova Raeva, Lilia M ^a   Xia, Guo liang ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGH THROUGHPUT SEQUENCING; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC TREE; PRIORITY JOURNAL; PYROSEQUENCING; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; AFRICA, WESTERN; CLUSTER ANALYSIS; EPIDEMICS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; NIGERIA; PHYLOGENY; POLYMORPHISM, GENETIC; POPULATION GROUPS; PREVALENCE; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84862694989     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.042184-0     Document Type: Article

References (60)

1. Adewole, O. O., Anteyi, E., Ajuwon, Z., Wada, I., Elegba, F., Ahmed, P., Betiku, Y., Okpe, A., Eze, S. & other authors (2009). Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries 3, 369-375.
2. Agwale, S. M., Tanimoto, L., Womack, C., Odama, L., Leung, K., Duey, D., Negedu-Momoh, R., Audu, I., Mohammed, S. B. & other authors (2004). Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 31 (Suppl. 1), S3-S6.
3. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A. & Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341, 556-562.
4. Balogun, T. M., Emmanuel, S. & Wright, K. O. (2010). Hepatitis C virus co infection in HIV positive patients. Nig Q J Hosp Med 20, 117-120.
5. Bracho, M. A., Carrillo-Cruz, F. Y., Ortega, E., Moya, A. & Gonzalez-Candelas, F. (2006). A new subtype of hepatitis C virus genotype 1: complete genome and phylogenetic relationships of an Equatorial Guinea isolate. J Gen Virol 87, 1697-1702.
6. Bekondi, C., Mobima, T., Ouavènè, J. O., Koffi, B., Konamna, X., Béré, A. & Le Faou, A. (2010). [Etiopathological factors of hepatocellular carcinoma in Bangui, Central African Republic: clinical, biological characteristics and virological aspects of patients]. Pathol Biol (Paris) 58, 152-155.
7. Candotti, D., Temple, J., Sarkodie, F. & Allain, J. P. (2003). Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77, 7914-7923.
8. Drummond, A. J. & Rambaut, A. (2007). BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7, 214.
9. EASL (1999). EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 31 (Suppl. 1), 3-8.
10. Excoffier, L., Laval, G. & Schneider, S. (2005). ARLEQUIN (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1, 47-50.
11. Ferraro, D., Genovese, D., Argentini, C., Giordano, V., Pizzillo, P., Stroffolini, T., Craxi, A., Rapicetta, M. & Di Stefano, R. (2008). Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: the Camporeale model. J Med Virol 80, 1723-1731.
12. Forbi, J. C., Vaughan, G., Purdy, M. A., Campo, D. S., Xia, G. L., Ganova-Raeva, L. M., Ramachandran, S., Thai, H. & Khudyakov, Y. E. (2010). Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS ONE 5, e11615.
13. Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., El Khoby, T., Abdel-Wahab, Y., Aly Ohn, E. S. & other authors (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355, 887-891.
14. Hnatyszyn, H. J. (2005). Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 10, 1-11.
15. Itskowitz, M. S. (2007). Hepatitis C: epidemiology, diagnosis, and management. Compr Ther 33, 87-93.
16. Jeannel, D., Fretz, C., Traore, Y., Kohdjo, N., Bigot, A., Pê Gamy, E., Jourdan, G., Kourouma, K., Maertens, G. & other authors (1998). Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 55, 92-97.
17. Lampe, E., Espirito-Santo, M. P., Martins, R. M. & Bello, G. (2010). Epidemic history of Hepatitis C virus in Brazil. Infect Genet Evol 10, 886-895.
18. Laraba, A., Wadzali, G., Sunday, B., Abdulfatai, O. & Fatai, S. (2010). Hepatitis C virus infection in Nigerians with chronic liver disease. The Internet Journal of Gastroenterology 9.
19. Lindenbach, B. D. & Rice, C. M. (2005). Unravelling hepatitis C virus replication from genome to function. Nature 436, 933-938.
20. Magiorkinis, G., Magiorkinis, E., Paraskevis, D., Ho, S. Y., Shapiro, B., Pybus, O. G., Allain, J. P. & Hatzakis, A. (2009). The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 6, e1000198.
21. Markov, P. V., Pepin, J., Frost, E., Deslandes, S., Labbé, A. C. & Pybus, O. G. (2009). Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol 90, 2086-2096.
22. Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L., Simmonds, P. & The International HCV Collaborative Study Group (1995). Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 76, 2493-2507.
23. Millar, J. D. & Foege, W. H. (1969). Status of eradication of smallpox (and control of measles) in West and Central Africa. J Infect Dis 120, 725-732.
24. Mustapha, S. K., Bolori, M. T., Ajayi, N. A., Nggada, H. A., Pindiga, U. H., Gashau, W. & Khalil, M. I. A. (2007). Hepatitis C virus antibodies in Nigerians with hepatocellular carcinoma. The Internet Journal of Oncology 4.
25. Nagalo, M. B., Sanou, M., Bisseye, C., Kaboré, M. I., Nebie, Y. K., Kienou, K., Kiba, A., Dahourou, H., Ouattara, S. & other authors (2011). Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus 4, 1-6.
26. Nakano, T., Lau, G. M., Lau, G. M., Sugiyama, M. & Mizokami, M. (2012). An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 32, 339-345.
27. Ndjomou, J., Pybus, O. G. & Matz, B. (2003). Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol 84, 2333-2341.
28. Ndong-Atome, G. R., Njouom, R., Padilla, C., Bisvigou, U., Makuwa, M. & Kazanji, M. (2009). Absence of intrafamilial transmission of hepatitis C virus and low risk for sexual transmission in rural central Africa indicate a cohort effect. J Clin Virol 45, 349-353.
29. Nei, M. (1987). Molecular Evolutionary Genetics. New York: Columbia University Press.
30. Newton, M. A., Raftery, A. E., Davison, A. C., Bacha, M., Celeux, G., Carlin, B. P., Clifford, P., Lu, C., Sherman, M. & other authors (1994). Approximate Bayesian-inference with the weighted likelihood bootstrap. J Roy Stat Soc B Met 56, 3-48.
31. Njouom, R., Pasquier, C., Ayouba, A., Gessain, A., Froment, A., Mfoupouendoun, J., Pouillot, R., Dubois, M., Sandres-Sauné, K. & other authors (2003). High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71, 219-225.
32. Njouom, R., Pasquier, C., Ayouba, A., Tejiokem, M. C., Vessiere, A., Mfoupouendoun, J., Tene, G., Eteki, N., Lobe, M. M., Izopet, J. & other authors (2005). Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg 73, 460-466.
33. Njouom, R., Nerrienet, E., Dubois, M., Lachenal, G., Rousset, D., Vessière, A., Ayouba, A., Pasquier, C. & Pouillot, R. (2007). The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol 7, 361-367.
34. Njouom, R., Frost, E., Deslandes, S., Mamadou-Yaya, F., Labbe, A. C., Pouillot, R., Mbelesso, P., Mbadingai, S., Rousset, D. & Pepin, J. (2009). Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J Gen Virol 90, 2452-2456.
35. Nwankiti, O. O., Ndako, J. A., Echeonwu, G. O., Olabode, A. O., Nwosuh, C. I., Onovoh, E. M., Okeke, L. A., Akinola, J. O., Duru, B. N. &other authors (2009). Hepatitis C virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol J 6, 110.
36. Ocama, P. & Seremba, E. (2011). Management of HIV and Hepatitis C Virus Infections in Resource-Limited Settings. Curr Opin HIV AIDS 6, 539-545.
37. Onakewhor, J. U. & Okonofua, F. E. (2009). Seroprevalence of Hepatitis C viral antibodies in pregnancy in a tertiary health facility in Nigeria. Niger J Clin Pract 12, 65-73.
38. Oni, A. O. & Harrison, T. J. (1996). Genotypes of hepatitis C virus in Nigeria. J Med Virol 49, 178-186.
39. Pasquier, C., Njouom, R., Ayouba, A., Dubois, M., Sartre, M. T., Vessière, A., Timba, I., Thonnon, J., Izopet, J. & Nerrienet, E. (2005). Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 77, 390-398.
40. Pépin, J. & Labbé, A. C. (2008). Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses. Trop Med Int Health 13, 744-753.
41. Pépin, J., Lavoie, M., Pybus, O. G., Pouillot, R., Foupouapouognigni, Y., Rousset, D., Labbé, A. C. & Njouom, R. (2010). Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis 51, 768-776.
42. Pouillot, R., Lachenal, G., Pybus, O. G., Rousset, D. & Njouom, R. (2008a). Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol 8, 676-681.
43. Pouillot, R., Lachenal, G., Pybus, O. G., Rousset, D. & Njouom, R. (2008b). Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol 8, 676-681.
44. Pybus, O. G., Charleston, M. A., Gupta, S., Rambaut, A., Holmes, E. C. & Harvey, P. H. (2001). The epidemic behavior of the hepatitis C virus. Science 292, 2323-2325.
45. Ramachandran, S., Xia, G. L., Ganova-Raeva, L. M., Nainan, O. V. & Khudyakov, Y. (2008). End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods 151, 217-224.
46. Ruggieri, A., Argentini, C., Kouruma, F., Chionne, P., D'Ugo, E., Spada, E., Dettori, S., Sabbatani, S. & Rapicetta, M. (1996). Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 77, 2073-2076.
47. Shepard, C. W., Finelli, L. & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558-567.
48. Simmonds, P., Holmes, E. C., Cha, T. A., Chan, S. W., McOmish, F., Irvine, B., Beall, E., Yap, P. L., Kolberg, J. & Urdea, M. S. (1993). Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74, 2391-2399.
49. Simmonds, P., Bukh, J., Combet, C., Deléage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspé, G., Kuiken, C. & other authors (2005). Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962-973.
50. Skums, P., Dimitrova, Z., Campo, D. S., Vaughan, G., Rossi, L., Forbi, J. C., Yokosawa, J., Zelikovsky, A. & Khudyakov, Y. (2012). Efficient error correction for deep sequencing of viral amplicons. BMC Bioinformatics. (In press)
51. Smith, D. B., Pathirana, S., Davidson, F., Lawlor, E., Power, J., Yap, P. L. & Simmonds, P. (1997). The origin of hepatitis C virus genotypes. J Gen Virol 78, 321-328.
52. Stuyver, L., Wyseur, A., van Arnhem, W., Lunel, F., Laurent-Puig, P., Pawlotsky, J.-M., Kleter, B., Bassit, L., Nkengasong, J., van Doorn, L.-J. & other authors (1995). Hepatitis C virus genotyping by means of 59-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 38, 137-157.
53. Tamura, K., Nei, M. & Kumar, S. (2004). Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 101, 11030-11035.
54. Tanaka, Y., Hanada, K., Mizokami, M., Yeo, A. E. T., Shih, J. W. K., Gojobori, T. & Alter, H. J. (2002). A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99, 15584-15589.
55. Tscherne, D. M., Evans, M. J., von Hahn, T., Jones, C. T., Stamataki, Z., McKeating, J. A., Lindenbach, B. D. & Rice, C. M. (2007). Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81, 3693-3703.
56. Viazov, S., Widell, A. & Nordenfelt, E. (2000). Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 28, 21-25.
57. Viazov, S., Ross, S. S., Kyuregyan, K. K., Timm, J., Neumann-Haefelin, C., Isaeva, O. V., Popova, O. E., Dmitriev, P. N., El Sharkawi, F. & other authors (2010). Hepatitis C virus recombinants are rare even among intravenous drug users. J Med Virol 82, 232-238.
58. Wansbrough-Jones, M. H., Frimpong, E., Cant, B., Harris, K., Evans, M. R. & Teo, C. G. (1998). Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg 92, 496-499.
59. WHO (1999). Hepatitis C: Weekly Epidemiological Record. No. 49, 10 December 1999, World Health Organisation Fact sheet no. 164.
60. Zeuzem, S. (2004). Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 140, 370-381.